Banca Mediolanum Spa BANCA MEDIOL.../ IT0004776628 /
| 2024-05-23 5:36:21 PM | Chg. +0.05 | Volume | Bid5:40:08 PM | Ask5:40:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 10.69EUR | +0.47% | 431,360 Turnover: 4.53 mill. |
-Bid Size: - | -Ask Size: - | 7.97 bill.EUR | 5.50% | 15.16 |
GlobeNewswire
02-07
The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, fir...
GlobeNewswire
2023-11-07
Acticor Biotech has just and timely completed patient recruitment of its phase 2/3 study in stroke
GlobeNewswire
2023-09-14
Acticor adapts its ACTISAVE clinical study to prepare the registration of glenzocimab for the treatm...
GlobeNewswire
2021-04-15
While ElsaLys continues to work on the filing of marketing approval in Europe and the U.S. for inoli...
GlobeNewswire
2021-01-19
Consortium including ElsaLys Biotech and Novadiscovery awarded €3.35 million by Bpifrance to advance...
